论文信息 - Abstract 3600: The prominent safety profile of TAS-115, a novel c-Met + VEGFR dual kinase inhibitor can lead to potentiate the efficacy via durable inhibition of angiogenesis - 字舞流文

Abstract 3600: The prominent safety profile of TAS-115, a novel c-Met + VEGFR dual kinase inhibitor can lead to potentiate the efficacy via durable inhibition of angiogenesis

Masanori Kato | Kimihiro Ito | S. Ito | Y. Aoyagi | T. Takenaka | Y. Suda | K. Miyadera | A. Sato | Takamasa Suzuki | H. Ochiiwa | A. Hashimoto | K. Yonekura | H. Fujita | Y. Fujioka | H. Kazuno | Jinhong Huang | T. Suefuji | Kousuke Egami | T. Sato